Evaluation of EGFR mutations in NSCLC with highly sensitive droplet digital PCR assays

Abstract excerpt

Targeted drugs have been widely used in the treatment of patients with lung cancer, particularly for those with non‑small cell lung cancer (NSCLC). Plasma cell‑free DNA is an emerging clinical tool for the detection of epidermal growth factor receptor (EGFR) gene mutation in patients with lung cancer. Detection of circulating tumor (ct) DNA by droplet digital PCR (ddPCR) is a highly sensitive and minimally...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Innovative Microfluidic and Catalytic Techniques Innovation
• Share to Monoclonal and Polyclonal Antibodies Research